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Deficiencies of the liver mitochondrial aspartate/glutamate antiporter citrin cause either neonatal intrahepatic cholestasis (NICCD; MIM #605814) or, in adults, the urea cycle disease citrullinemia type 2 (CTLN2; MIM #603471) [1, 2] . These diseases, which are associated with mutations in the citrin-encoding gene SLC25A13 (MIM 603859), were reported in Japan and are generally believed to affect only East-Asian populations, thus being neglected in the western world, where, for example, CTLN2
was not included in a recent urea cycle disorders guideline [3] . The relevance of citrin deficiency in western countries is highlighted here by reporting NICCD in a Romanian child living in Spain. We also provide detailed data supporting the immediate efficacy of nutritional NICCD treatment. The finding in this patient in homozygosis of the c.1078C>T nonsense (p.Arg360*) mutation in the SLC25A13 gene, and the previous report of the same mutation in one Czech and one Japanese patient [4] suggests that this mutation might be relatively widespread.
Case report.
The patient, a male, was the third child of healthy non-consanguineous Romanian parents. He was admitted to our hospital at age 22 days with jaundice and inadequate thriving with breastfeeding. Modest hepatomegaly (2 cm) was found, and laboratory tests confirmed the jaundice (total bilirrubin, 182 µmol/L; nv <10) and revealed lowered total plasma proteins and albumin levels (34 and 26 g/L, respectively), profound anemia (67 g hemoglobin/L) requiring packed red blood cells transfusion, and impaired coagulation reflected in lengthened prothrombin time, due to decreased protein K-dependent coagulation factors VII and IX (respective levels, 30% and 48%; nv >70% for both). He presented also hypoglycemia (32 mg/L), galactosuria increased AFP levels, raised a strong suspicion of NICCD [6] , and thus breast milk was replaced on day 40 of life by a lactose-free, carbohydrate-low infant formula enriched in protein and medium chain triglycerides, providing per day 2.5-3.5 gr protein/kg body weight [7] . The SLC25A13 gene (reference Genbank sequence,NM_014251. 
Discussion
The p.Arg360* mutation found in this child is obviously disease-causing. The fact that the child is homozygous for it although his parents are non-consanguineous, and the earlier report of this mutation [4] in a Caucasian Czech NICCD patient and in a Japanese baby, suggests that this mutation may be widespread, particularly in central Europe. Nevertheless, the only Romanian patient among the eight previously reported unrelated Caucasian patients with NICCD [4, [7] [8] [9] [10] carried in homozygosis a different SLC25A13 mutation than that reported here [10] .
The apparently immediate effectiveness of the lactose-free, low-carbohydrate protein-enriched formula (Fig. 1) highlights the need to be aware of this very rare disease in Western countries, particularly since NICCD not always follows a benign course [11] , what might be related with inappropriate treatment. Indeed, NICCD should always be considered in the differential diagnosis of neonatal cholestasis [12] , with a strong suspicion of NICCD being aroused by the triad of galactosuria, increased AFP and increased plasma amino acids (citrulline, threonine, methionine and tyrosine) [6] .
Confirmatory diagnosis requires molecular analysis of the SLC25A13 gene, although the failure of anti-citrin antibodies (available commercially) to reveal citrin in western blots of lymphocytes or fibroblasts is also diagnostic [13] . However, this last trait is not observed in all patients [9] . In view of the prompt therapeutic response, in cases of strong suspicion of citrin deficiency, dietary treatment under close patient monitoring can be initiated without waiting for molecular diagnosis. 
